Kwality Pharmaceuticals Limited, together with its subsidiary, manufactures finished pharmaceutical formulations in India and internationally. The company offers its products in various dosage forms, including liquid orals, powder for oral suspension, dry syrups, tablets, capsules, sterile powder for injections, small volume parentals (liquid and lyophilized), pre filled syringes, ointments and creams, ophthalmic preparations, eye/ear drops, sanitizers, suppositories, injectable vials and ampoules, lyophilized products, syrups, daunorubicin, and various other categories such as general, beta-lactam, cephalosporins, cytotoxic (oncology), and biological. It also provides intermediates, chemicals, extracts, alkaloids, toilet requisites, beverages, and other medical preparations. Kwality Pharmaceuticals Limited was incorporated in 1983 and is based in Amritsar, India.
| Current Price | ₹2,293.90 |
|---|---|
| Market Cap | ₹2,380 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Medicinal Chemicals and Botanical Products |
| P/E Ratio | 35.3 |
| Return on Equity | 22.74% |
| 52-Week Range | ₹1,561.00 – ₹2,440.00 |
| Beta (1Y) | 1.15 |
| Dividend Yield | 0.00% |
1. Pharmaceuticals-100%
Kwality Pharmaceuticals Ltd is trading at ₹2,293.90, with a market capitalisation of ₹2,380 Cr.
Kwality Pharmaceuticals Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Medicinal Chemicals and Botanical Products).
Kwality Pharmaceuticals Ltd has a P/E of 35.3 and a return on equity of 22.74%.